Monopar Therapeutics Inc (MNPR) earnings · $431.4M cap
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
This MNPR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
When the next MNPR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for MNPR. We will not invent a beat or miss.
Not investment advice. Full MNPR research stays on the stock page; the tape stays on the quote page.
Not investment advice.